SALEM INVESTMENT COUNSELORS INC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 79 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2019. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.

Quarter-by-quarter ownership
SALEM INVESTMENT COUNSELORS INC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q3 2021$3,000
-25.0%
8500.0%0.00%
Q2 2021$4,0000.0%8500.0%0.00%
Q1 2021$4,000
+33.3%
8500.0%0.00%
Q4 2020$3,0000.0%8500.0%0.00%
Q3 2020$3,000
-25.0%
8500.0%0.00%
Q2 2020$4,0000.0%8500.0%0.00%
Q1 2020$4,000
+33.3%
8500.0%0.00%
Q4 2019$3,000
-57.1%
8500.0%0.00%
-100.0%
Q3 2019$7,000
-12.5%
8500.0%0.00%0.0%
Q2 2019$8,000
-46.7%
850
+70.0%
0.00%
-50.0%
Q1 2017$15,0005000.00%
Other shareholders

There were no reported owners of LA JOLLA PHARMACEUTICAL CO in Q4 2019.

NameSharesValueWeighting ↓
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders